Leango-Var is a once-weekly subcutaneous injectable with dual agonism of GIP and GLP-1 receptors, helping both appetite regulation and glycemic control. In comparison, other injectable weight loss medications, such as Wegovy, primarily target GLP-1 only, focusing on appetite suppression and weight reduction. The dual action of Leango-Var may result in more gradual and sustainable weight loss along with broader metabolic benefits, particularly in patients who have both obesity and type 2 diabetes.
Leango-Var vs Oral Weight Loss Medications
Oral weight loss agents, including Orlistat or certain oral GLP-1 agonists, typically have limited effects on appetite and mainly act by reducing fat absorption or providing modest metabolic impact. Leango-Var, through subcutaneous injection and direct hormonal pathway activation, offers not only effective weight reduction but also improvements in glycemic control and insulin sensitivity. This makes it a differentiated and targeted option for patients seeking both weight management and type 2 diabetes support.
2 پاسخ
خیلی عالی بود
ممنون از شما